Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma.
Ann Oncol
; 28(5): 1130-1136, 2017 May 01.
Article
in En
| MEDLINE
| ID: mdl-28327969
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Programmed Cell Death 1 Receptor
/
Circulating Tumor DNA
/
Melanoma
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Country of publication:
United kingdom